Medical Device Procurement in the United Kingdom: A Supplier's Guide [2026]

The United Kingdom represents one of the world's most significant medical device markets, with the NHS serving over 67 million people. Post-Brexit, the UK has established its own regulatory framework separate from the EU, creating both challenges and opportunities for medical device suppliers. Understanding the MHRA regulatory pathway, UKCA marking requirements, and NHS procurement mechanisms is essential for market success.

Regulatory authority and approval pathway

The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK's competent authority for medical devices. Post-Brexit, the UK has diverged from the EU MDR framework:

• UKCA marking: The UK Conformity Assessed mark is required for devices placed on the Great Britain market (England, Scotland, Wales). CE marks from EU Notified Bodies are accepted under extended transition arrangements, but UKCA will eventually be mandatory.
• UK Approved Bodies: UKCA marking requires assessment by a UK Approved Body (e.g., BSI UK). The number of approved bodies is limited, so plan for longer assessment timelines.
• Device registration: All medical devices must be registered with MHRA before being placed on the UK market. Registration requires a UK Responsible Person (UKRP) for non-UK manufacturers.
• Northern Ireland: Under the Windsor Framework, Northern Ireland follows EU MDR rules. CE marking remains valid in Northern Ireland.

The dual CE/UKCA requirement means suppliers targeting both UK and EU markets must maintain two regulatory pathways. Our EU MDR guide covers the European side.

Key procurement platforms and channels

NHS procurement is centralized through several key organizations:

• NHS Supply Chain: Managed by Supply Chain Coordination Limited (SCCL), NHS Supply Chain operates framework agreements covering the majority of NHS trusts. Winning a framework position provides access to hundreds of hospitals.
• Crown Commercial Service (CCS): Government-wide procurement frameworks that NHS organizations can use for technology and services.
• Contracts Finder: The UK government's public procurement portal where all above-threshold opportunities are published.
• Find a Tender Service (FTS): Post-Brexit replacement for TED, where high-value public contracts are advertised.
• Individual NHS Trust tenders: Trusts can run their own procurement outside framework agreements, particularly for specialized or innovative devices.

NHS Supply Chain framework agreements are the primary commercial gateway. MedStrato tracks NHS tenders across all portals and frameworks in real time.

Compliance requirements for tenders

• NICE evaluation: The National Institute for Health and Care Excellence evaluates clinical and cost-effectiveness. A positive NICE Medical Technologies Guidance (MTG) or Diagnostics Guidance (DG) dramatically increases NHS adoption.
• NHS clinical evaluation: Many tenders require evidence of clinical effectiveness specific to NHS settings and patient populations.
• PAS ID/Single Qualification Questionnaire: Standard pre-qualification frameworks assessing financial standing, technical capacity, and compliance history.
• Information governance: NHS Digital's Data Security and Protection Toolkit (DSPT) compliance is required for any device that processes patient data.
• Social value: Under the Procurement Act 2023, tenders must demonstrate social value contribution (typically 10-20% weighting).

Market size and opportunity

The UK medical device market is valued at approximately GBP 12 billion. Key areas of opportunity include:

• Diagnostics: Point-of-care diagnostics remain a priority following pandemic-era investment in testing infrastructure.
• Digital health: NHS transformation programs actively seek digital solutions for remote monitoring, AI diagnostics, and clinical decision support.
• Elective care recovery: Addressing surgical backlogs drives demand for theatre equipment, instruments, and implants.

Tips for foreign suppliers

1. Appoint a UK Responsible Person: Required by MHRA for all non-UK manufacturers. Choose a UKRP with regulatory expertise, not just a registered address.
2. Seek NICE evaluation early: A positive NICE recommendation transforms your commercial trajectory in the NHS. Engage NICE's Office for Market Access before your UK launch.
3. Target NHS Supply Chain frameworks: Framework inclusion provides the most efficient path to volume across NHS trusts.
4. Understand NHS payment mechanisms: National Tariff Payment System (NTPS) determines how trusts are reimbursed. Align your value proposition to tariff economics.
5. Leverage automated tender intelligence: NHS procurement is high-volume and deadline-driven. Automated tender management is essential. Book a demo to see how MedStrato handles UK procurement.